Home › Funds › Banque Cantonale Vaudoise › ABT

Banque Cantonale Vaudoise position in ABT

ABBOTT LABORATORIES · Health Care

Banque Cantonale Vaudoise reported holding 123,800 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 0.42% of its reported portfolio and ranking #41 among its reported holdings. Banque Cantonale Vaudoise has disclosed ABT holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)123.80K sh
Reported value held$12.23M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeNew
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Banque Cantonale Vaudoise's ABT position evolved

Banque Cantonale Vaudoise first disclosed a stake in ABT in Q3 2023 at 130,379 shares (US$12.6M). The position peaked in Q2 2025 at 94,462 shares, worth US$12.8M. Across 10 filings, Banque Cantonale Vaudoise increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 123,800 shares valued at US$12.2M. Notable position changes include a 30% trim in Q4 2023 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 130.38K $12.63M New
Q4 2023 91.32K $10.05M Reduce
Q1 2024 95.08K $10.80M Add
Q3 2024 93.36K $10.64M Reduce
Q1 2025 88.64K $11.76M Reduce
Q2 2025 94.46K $12.85M Add
Q3 2025 90.60K $12.13M Reduce
Q4 2025 96.35K $12.07M Add
Q1 2026 78.75K $8.09M Reduce
Q3 2026 123.80K $12.23M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Banque Cantonale Vaudoise held ABT?

Banque Cantonale Vaudoise has disclosed ABT holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Banque Cantonale Vaudoise's current position in ABT?

As of Q3 2026, Banque Cantonale Vaudoise holds 123.80K shares of ABT (ABBOTT LABORATORIES), valued at $12.23M, representing 0.42% of its reported portfolio and ranking #41.

Has Banque Cantonale Vaudoise been buying or selling ABT?

In the latest 13F filing (Q3 2026), Banque Cantonale Vaudoise newly opened its position in ABT. The position peaked in Q2 2025 at 94.46K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.